KR19990001564A
(ko)
*
|
1997-06-16 |
1999-01-15 |
유충식 |
용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
|
KR100514330B1
(ko)
*
|
1997-12-31 |
2006-02-17 |
주식회사 중외제약 |
난용성 약물을 함유하는 코팅정
|
PT1039909E
(pt)
|
1997-12-31 |
2003-02-28 |
Choongwae Pharma Corp |
Metodo de producao e composicao de uma preparacao oral de itraconazole
|
KR100288890B1
(ko)
*
|
1997-12-31 |
2001-05-02 |
최현식 |
이트라코나졸 경구용 제제 및 그의 제조방법
|
ES2157731B1
(es)
*
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
IL145140A0
(en)
|
1999-03-24 |
2002-06-30 |
Fmc Corp |
Improved aqueous solubility pharmaceutical formulations
|
KR100331529B1
(ko)
*
|
1999-06-16 |
2002-04-06 |
민경윤 |
난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
|
EP1175205B1
(en)
|
1999-11-12 |
2006-06-14 |
Abbott Laboratories |
Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
|
AU2331801A
(en)
|
1999-12-23 |
2001-07-09 |
F.H. Faulding & Co. Limited |
Improved pharmaceutical compositions for poorly soluble drugs
|
FR2803748A1
(fr)
*
|
2000-01-14 |
2001-07-20 |
Ethypharm Lab Prod Ethiques |
Composition d'itraconazole et procede de preparation
|
DE10026698A1
(de)
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
RU2333757C2
(ru)
*
|
2000-06-22 |
2008-09-20 |
Новартис Аг |
Фармацевтические композиции
|
DE10038571A1
(de)
*
|
2000-08-03 |
2002-02-14 |
Knoll Ag |
Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
AU2002302363B2
(en)
|
2001-02-14 |
2008-05-01 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
|
OA12464A
(en)
|
2001-04-09 |
2006-05-24 |
Tibotec Pharm Ltd |
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.
|
PT1387842E
(pt)
|
2001-05-11 |
2009-07-20 |
Tibotec Pharm Ltd |
2-aminobenzoxazolsulfonamidas inibidoras de largo espectro da protease hiv
|
WO2002100407A1
(en)
*
|
2001-06-12 |
2002-12-19 |
Smartrix Technologies Inc. |
Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
|
ES2333645T3
(es)
|
2001-06-22 |
2010-02-25 |
Bend Research, Inc. |
Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros.
|
KR100455216B1
(ko)
*
|
2001-06-27 |
2004-11-09 |
한미약품 주식회사 |
난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법
|
US7163700B2
(en)
*
|
2001-07-31 |
2007-01-16 |
Capricorn Pharma, Inc. |
Amorphous drug beads
|
KR100438485B1
(ko)
*
|
2001-08-13 |
2004-07-09 |
한국디디에스제약 주식회사 |
아졸류 항진균제의 약제학적 조성물
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
BR0212833A
(pt)
|
2001-09-26 |
2004-10-13 |
Baxter Int |
Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
|
UA79248C2
(en)
|
2001-11-09 |
2007-06-11 |
Janssen Pharmaceutica Nv |
Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
|
CA2363376A1
(en)
*
|
2001-11-16 |
2003-05-16 |
Bernard Charles Sherman |
Solid pharmaceutical compositions for oral administration comprising itraconazole
|
US6455557B1
(en)
|
2001-11-28 |
2002-09-24 |
Elan Pharmaceuticals, Inc. |
Method of reducing somnolence in patients treated with tizanidine
|
US20040220240A1
(en)
*
|
2001-11-28 |
2004-11-04 |
Pellegrini Cara A. |
Method of increasing the extent of absorption of tizanidine
|
TWI336621B
(en)
|
2001-12-21 |
2011-02-01 |
Tibotec Pharm Ltd |
Broad spectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
|
HRP20020124A2
(en)
*
|
2002-02-11 |
2003-10-31 |
Pliva D D |
Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
|
ZA200502495B
(en)
|
2002-02-28 |
2005-09-20 |
Japan Tobacco Inc |
Ester compound and medicinal use thereof.
|
MY142238A
(en)
|
2002-03-12 |
2010-11-15 |
Tibotec Pharm Ltd |
Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
|
DE60315984T2
(de)
|
2002-05-17 |
2008-05-29 |
Tibotec Pharmaceuticals Ltd. |
Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
|
WO2004004683A1
(en)
*
|
2002-07-04 |
2004-01-15 |
Janssen Pharmaceutica N.V. |
Solid dispersions comprising two different polymer matrixes
|
AU2003262574B2
(en)
|
2002-08-14 |
2009-07-09 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
|
EP2422775A3
(en)
*
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestering subunit and related compositions and methods
|
US20040086567A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Pawan Seth |
Bioequivalent composition of itraconazole and a hydrophilic polymer
|
SI1438961T2
(sl)
*
|
2003-01-14 |
2014-12-31 |
Cimex Pharma Ag |
Bioekvivalenten sestavek itrakonazola, dispergiranega v hidrofilnem polimeru
|
CN100594023C
(zh)
*
|
2003-02-03 |
2010-03-17 |
诺瓦提斯公司 |
药物制剂
|
FR2857591B1
(fr)
*
|
2003-07-17 |
2007-11-02 |
Ethypharm Sa |
Particules comprenant un principe actif sous forme de co-precipite
|
BRPI0412734A
(pt)
*
|
2003-07-17 |
2006-09-26 |
Tibotec Pharm Ltd |
processo para preparação de partìculas que contêm um antiviral
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
EP1669345A4
(en)
*
|
2003-08-29 |
2008-02-20 |
Japan Tobacco Inc |
ESTER DERIVATIVE AND MEDICAL USE THEREOF
|
US20050058670A1
(en)
*
|
2003-09-09 |
2005-03-17 |
Jong-Soo Woo |
Oral itraconazole composition which is not affected by ingested food and process for preparing same
|
UA84020C2
(ru)
|
2003-09-11 |
2008-09-10 |
Тиботек Фармасьютикелз Лтд. |
Ингибитор проникновения вируса вил
|
US20050118265A1
(en)
*
|
2003-11-28 |
2005-06-02 |
Anandi Krishnan |
Antifungal oral dosage forms and the methods for preparation
|
GB0403098D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Extrusion
|
TWI350762B
(en)
*
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
JP2007526341A
(ja)
*
|
2004-03-03 |
2007-09-13 |
スフェリックス, インコーポレイテッド |
疎水性薬物のためのポリマー薬物送達システム
|
AR048650A1
(es)
|
2004-05-04 |
2006-05-10 |
Tibotec Pharm Ltd |
Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
|
EP1750696B1
(en)
|
2004-05-07 |
2013-06-26 |
Sequoia Pharmaceuticals Inc |
RETROVIRAL PROTEASE INHIBITORS RESISTING THEIR RESISTANCE
|
AR049637A1
(es)
|
2004-05-17 |
2006-08-23 |
Tibotec Pharm Ltd |
1-fenil-1,5-dihidro-pirido[3,2-b]indol-2-onas sustituidas en las posiciones 6, 7, 8, 9
|
WO2005111044A1
(en)
|
2004-05-17 |
2005-11-24 |
Tibotec Pharmaceuticals Ltd. |
4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
|
AP2006003791A0
(en)
|
2004-05-17 |
2006-10-31 |
Tibotec Pharm Ltd |
1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones
|
WO2005117834A1
(en)
*
|
2004-05-27 |
2005-12-15 |
Janssen Pharmaceutica N.V. |
Solid dispersions of a basic drug compound and a polymer containing acidic groups
|
KR20050119397A
(ko)
*
|
2004-06-16 |
2005-12-21 |
보람제약주식회사 |
고상용해를 이용한 난용성 약물의 가용화 방법과 이를이용한 가용화 조성물
|
US20060030623A1
(en)
*
|
2004-07-16 |
2006-02-09 |
Noboru Furukawa |
Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
|
KR100708974B1
(ko)
*
|
2004-07-19 |
2007-04-18 |
주식회사종근당 |
수용성 수지를 이용한 이트라코나졸 고체분산체
|
WO2006026504A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
US20060045865A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
US8101774B2
(en)
*
|
2004-10-18 |
2012-01-24 |
Japan Tobacco Inc. |
Ester derivatives and medicinal use thereof
|
CA2582767C
(en)
*
|
2004-10-25 |
2011-05-24 |
Japan Tobacco Inc. |
Solid formulation with improved solubility and stability and method for producing said formulation
|
US9504658B2
(en)
|
2004-11-09 |
2016-11-29 |
Board Of Regents, The University Of Texas System |
Stabilized HME composition with small drug particles
|
DK1848430T3
(da)
*
|
2004-12-31 |
2017-11-06 |
Dr Reddys Laboratories Ltd |
Nye benzylamin-derivativer som cetp-inhibitors
|
US8604055B2
(en)
|
2004-12-31 |
2013-12-10 |
Dr. Reddy's Laboratories Ltd. |
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
|
AR056652A1
(es)
|
2005-04-11 |
2007-10-17 |
Tibotec Pharm Ltd |
Derivados de (1,10-b dihidro-2-(aminoalquil-fenil) -5h-pirazolo (1,5-c) (1,3)benzoxazin-5-il) fenilmetanona y su uso en la fabricacion de un medicamento
|
DE102005026755A1
(de)
*
|
2005-06-09 |
2006-12-14 |
Basf Ag |
Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
|
CA2618255C
(en)
*
|
2005-08-08 |
2015-05-26 |
Abbott Gmbh & Co. Kg |
Itraconazole compositions with improved bioavailability
|
JP2009504590A
(ja)
*
|
2005-08-08 |
2009-02-05 |
アボット ゲーエムベーハー ウント コンパニー カーゲー |
改善された生物学的利用能をもつ剤型
|
JP5435946B2
(ja)
*
|
2005-08-22 |
2014-03-05 |
ジョンズ ホプキンス ユニバーシティ |
疾患を処置するためのヘッジホッグ経路アンタゴニスト
|
AU2006338839A1
(en)
*
|
2006-02-23 |
2007-08-30 |
Iomedix Sleep International Srl |
Compositions and methods for the induction and maintenance of quality sleep
|
BRPI0709940A2
(pt)
|
2006-04-03 |
2011-08-02 |
Tibotec Pharm Ltd |
3,4-diidro-imidazo[4,5-b]piridin-5-onas para inibição do hiv
|
GB0607105D0
(en)
*
|
2006-04-10 |
2006-05-17 |
Leuven K U Res & Dev |
Enhancing solubility and dissolution rate of poorly soluble drugs
|
ES2622576T3
(es)
|
2006-06-19 |
2017-07-06 |
Alpharma Pharmaceuticals Llc |
Composiciones farmacéuticas
|
WO2008013416A1
(en)
*
|
2006-07-27 |
2008-01-31 |
Amorepacific Corporation |
Process for preparing powder comprising nanoparticles of sparingly soluble drug
|
US20080233156A1
(en)
*
|
2006-10-11 |
2008-09-25 |
Alpharma, Inc. |
Pharmaceutical compositions
|
JP2010526848A
(ja)
*
|
2007-05-11 |
2010-08-05 |
エフ.ホフマン−ラ ロシュ アーゲー |
難溶性薬物用の医薬組成物
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
CN101835492B
(zh)
*
|
2007-08-21 |
2012-11-21 |
德克萨斯州立大学董事会 |
用于制药应用的热动力学混合
|
WO2009034558A2
(en)
|
2007-09-14 |
2009-03-19 |
Wockhardt Research Centre |
Rhein or diacerein compositions
|
EP2520283A1
(en)
|
2007-09-27 |
2012-11-07 |
Wockhardt Limited |
Pharmaceutical compositions of rhein or diacerein
|
US20090130160A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Fiber Innovation Technology, Inc. |
Fiber for wound dressing
|
CA2707161C
(en)
|
2007-11-28 |
2016-08-16 |
Sequoia Pharmaceuticals, Inc. |
Compositions and methods for inhibiting cytochrome p450 2d6
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
WO2009079521A1
(en)
*
|
2007-12-17 |
2009-06-25 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
BRPI0905717A2
(pt)
*
|
2008-01-11 |
2015-07-14 |
Cipla Ltd |
Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
|
CA2716348C
(en)
|
2008-02-21 |
2017-04-04 |
Sequoia Pharmaceuticals, Inc. |
Diamide inhibitors of cytochrome p450
|
JP5607550B2
(ja)
|
2008-03-11 |
2014-10-15 |
ディポメド,インコーポレイティド |
非オピオイド鎮痛剤及びオピオイド鎮痛剤の組合せを含む胃保持性持続放出剤形
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
WO2009129300A2
(en)
*
|
2008-04-15 |
2009-10-22 |
Schering Corporation |
High density compositions containing posaconazole and formulations comprising the same
|
EA013132B1
(ru)
*
|
2008-12-31 |
2010-02-26 |
Открытое Акционерное Общество "Верофарм" |
Противогрибковое средство для вагинального применения
|
CN101780046B
(zh)
*
|
2009-01-16 |
2011-09-21 |
北京化工大学 |
一种伊曲康唑复合粉体及其制备方法
|
DK2512455T3
(en)
|
2009-12-18 |
2014-03-24 |
Frieslandcampina Nederland Holding B V |
Co-treated tablet adjuvant composition, its preparation and use
|
US9198861B2
(en)
|
2009-12-22 |
2015-12-01 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
US8597681B2
(en)
|
2009-12-22 |
2013-12-03 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
CN103237458A
(zh)
*
|
2010-10-14 |
2013-08-07 |
雅培股份有限两合公司 |
类姜黄素固体分散体制剂
|
CN102068416A
(zh)
*
|
2010-12-30 |
2011-05-25 |
安徽先求药业有限公司 |
一种含有伊曲康唑的口服固体制剂及其制备方法
|
WO2012110469A1
(en)
|
2011-02-17 |
2012-08-23 |
F. Hoffmann-La Roche Ag |
A process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion
|
US8741885B1
(en)
|
2011-05-17 |
2014-06-03 |
Mallinckrodt Llc |
Gastric retentive extended release pharmaceutical compositions
|
US8658631B1
(en)
|
2011-05-17 |
2014-02-25 |
Mallinckrodt Llc |
Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
US20140206717A1
(en)
*
|
2011-08-16 |
2014-07-24 |
John Higgins |
Use of inorganic matrix and organic polymer combinations for preparing stable amorphous dispersions
|
JP5964965B2
(ja)
|
2011-08-18 |
2016-08-03 |
ドクター レディズ ラボラトリーズ リミテッド |
コレステリルエステル転送タンパク質(cetp)インヒビターとしての置換複素環式アミン化合物
|
WO2013037396A1
(en)
*
|
2011-09-12 |
2013-03-21 |
Bioneer A/S |
Solution of polymer in api for a solid dosage form
|
CA2850022C
(en)
|
2011-09-27 |
2018-05-01 |
Dr. Reddy's Laboratories, Ltd. |
5 - benzylaminomethyl - 6 - aminopyrazolo [3,4-b] pyridine derivatives as cholesteryl ester-transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis
|
US20140128431A1
(en)
|
2012-04-03 |
2014-05-08 |
Hoffmann-Laroche Inc. |
Pharmaceutical composition with improved bioavailability, safety and tolerability
|
EP2649989B1
(en)
|
2012-04-13 |
2017-10-18 |
King Saud University |
Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof
|
BR112014031706A8
(pt)
|
2012-06-21 |
2021-10-19 |
Mayne Pharma Int Pty Ltd |
Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol
|
PT2874607T
(pt)
|
2012-07-17 |
2017-08-14 |
Dow Global Technologies Llc |
Resumo
|
AU2013346501B2
(en)
|
2012-11-19 |
2017-07-13 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical compositions of CETP inhibitors
|
CA2892025C
(en)
|
2013-01-22 |
2022-02-15 |
F. Hoffmann-La Roche Ag |
Solid dispersions comprising 4-{[(2r, 3s, 4r, 5s)-4-(4-chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3- methoxy -benzoic acid and pharmaceutical compositions comprising same with improved bioavailability
|
CN104721827A
(zh)
*
|
2013-12-18 |
2015-06-24 |
博瑞生物医药技术(苏州)有限公司 |
一种难溶性抗真菌药物固体分散体及其制备方法
|
JP6546179B2
(ja)
|
2014-01-16 |
2019-07-17 |
ダウ グローバル テクノロジーズ エルエルシー |
3d印刷用支持材料
|
JP6810060B2
(ja)
*
|
2015-06-09 |
2021-01-06 |
ダウ グローバル テクノロジーズ エルエルシー |
3d印刷用支持材料
|
WO2017196712A1
(en)
*
|
2016-05-09 |
2017-11-16 |
Dispersol Technologies, Llc |
Improved drug formulations
|
WO2019043427A1
(en)
|
2017-09-01 |
2019-03-07 |
Jordan Sweden Medical And Sterilization Company |
FAST SELF-DISPERSION DOSAGE FORMS OF DEFERASIROX
|
CN109172532A
(zh)
*
|
2018-10-24 |
2019-01-11 |
北京哈三联科技有限责任公司 |
一种伊曲康唑分散片及其制备方法和应用
|
BR112022003812A2
(pt)
*
|
2019-08-28 |
2022-05-24 |
Lubrizol Advanced Mat Inc |
Dispersão sólida amorfa, produto, e, métodos para administrar um ingrediente farmacêutico ativo a uma pessoa ou animal não humano e para formar uma dispersão sólida amorfa de um ingrediente farmacêutico ativo
|
KR102266145B1
(ko)
*
|
2019-09-26 |
2021-06-17 |
대봉엘에스 주식회사 |
비정질 에피나코나졸 고체 분산체
|
CN117835971A
(zh)
|
2021-08-25 |
2024-04-05 |
巴斯夫欧洲公司 |
直接压片用辅料组合物
|